We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
-6.78%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4.22B
AUM Growth
-$771M
Cap. Flow
-$291M
Cap. Flow %
-6.9%
Top 10 Hldgs %
17.96%
Holding
353
New
17
Increased
57
Reduced
195
Closed
19

Top Sells

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$38.9M
2
TDOC icon
Teladoc Health
TDOC
+$33.6M
3
META icon
Meta Platforms (Facebook)
META
+$31.8M
4
OKTA icon
Okta
OKTA
+$22.6M
5
LNTH icon
Lantheus
LNTH
+$18.4M

Sector Composition

Rank Sector Weight
1 Technology 21.26%
2 Healthcare 18.03%
3 Financials 14.95%
4 Consumer Discretionary 12.53%
5 Industrials 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWB
351
DELISTED
Great Western Bancorp, Inc.
GWB
-357,206
Closed -$12.1M
CCMP
352
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-85,575
Closed -$16.4M
REGI
353
DELISTED
Renewable Energy Group, Inc.
REGI
-240,074
Closed -$10.2M

Similar funds

Peregrine Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Peregrine Capital Management held 353 positions worth $4.22B, down 15% from $4.99B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Peregrine Capital Management withdrew a net $291M in Q1 2022, closing 19 positions and reducing 195 holdings. Its most notable exit was DocuSign, an estimated $38.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in Abiomed Inc worth $42.8M.

  • Peregrine Capital Management's largest Q1 2022 buy was Abiomed Inc: 129,135 shares worth $42.8M.
  • Peregrine Capital Management added most to Callon Petroleum Company in Q1 2022, an estimated $9.01M increase.
  • Peregrine Capital Management's biggest Q1 2022 reduction was Teladoc Health, cutting an estimated $33.6M.
  • Peregrine Capital Management fully exited DocuSign in Q1 2022, selling an estimated $38.9M.
  • Peregrine Capital Management's ten largest holdings make up 18% of its $4.22B portfolio in Q1 2022.
  • Peregrine Capital Management opened 17 new positions and closed 19 in Q1 2022.
  • Peregrine Capital Management's portfolio value fell 15% quarter-over-quarter to $4.22B.

Based on Peregrine Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.